Retinal degeneration and Alzheimer's disease: an evolving link

A Ashok, N Singh, S Chaudhary… - International journal of …, 2020 - mdpi.com
Age-related macular degeneration (AMD) and glaucoma are degenerative conditions of the
retina and a significant cause of irreversible blindness in developed countries. Alzheimer's …

Imaging Amyloid‐β Membrane Interactions: Ion‐Channel Pores and Lipid‐Bilayer Permeability in Alzheimer's Disease

JH Viles - Angewandte Chemie International Edition, 2023 - Wiley Online Library
The accumulation of the amyloid‐β peptides (Aβ) is central to the development of
Alzheimer's disease. The mechanism by which Aβ triggers a cascade of events that leads to …

Reversal of synapse loss in Alzheimer mouse models by targeting mGluR5 to prevent synaptic tagging by C1Q

J Spurrier, LS Nicholson, XT Fang, AJ Stoner… - Science translational …, 2022 - science.org
Microglia-mediated synaptic loss contributes to the development of cognitive impairments in
Alzheimer's disease (AD). However, the basis for this immune-mediated attack on synapses …

Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme

S Mead, A Khalili-Shirazi, C Potter, T Mok… - The Lancet …, 2022 - thelancet.com
Background Human prion diseases, including Creutzfeldt–Jakob disease (CJD), are rapidly
progressive, invariably fatal neurodegenerative conditions with no effective therapies. Their …

Effect of AZD0530 on cerebral metabolic decline in Alzheimer disease: a randomized clinical trial

CH Van Dyck, HB Nygaard, K Chen… - JAMA …, 2019 - jamanetwork.com
Importance Oligomeric amyloid-β peptide binds to cellular prion protein on the neuronal cell
surface, activating intracellular fyn kinase to mediate synaptotoxicity and tauopathy …

Neuronal transcriptome, tau and synapse loss in Alzheimer's knock-in mice require prion protein

A Stoner, L Fu, LS Nicholson, C Zheng… - Alzheimer's Research & …, 2023 - Springer
Abstract Background Progression of Alzheimer's disease leads to synapse loss, neural
network dysfunction and cognitive failure. Accumulation of protein aggregates and brain …

Liquid and hydrogel phases of PrPC linked to conformation shifts and triggered by Alzheimer's amyloid-β oligomers

MA Kostylev, MD Tuttle, S Lee, LE Klein, H Takahashi… - Molecular cell, 2018 - cell.com
Protein phase separation by low-complexity, intrinsically disordered domains generates
membraneless organelles and links to neurodegeneration. Cellular prion protein (PrP C) …

Structural differences in amyloid-β fibrils from brains of nondemented elderly individuals and Alzheimer's disease patients

U Ghosh, WM Yau, J Collinge… - Proceedings of the …, 2021 - National Acad Sciences
Although amyloid plaques composed of fibrillar amyloid-β (Aβ) assemblies are a diagnostic
hallmark of Alzheimer's disease (AD), quantities of amyloid similar to those in AD patients …

Cellular prion protein mediates the disruption of hippocampal synaptic plasticity by soluble tau in vivo

T Ondrejcak, I Klyubin, GT Corbett… - Journal of …, 2018 - Soc Neuroscience
Intracellular neurofibrillary tangles (NFTs) composed of tau protein are a neuropathological
hallmark of several neurodegenerative diseases, the most common of which is Alzheimer's …

Finding memo: versatile interactions of the VPS10p-Domain receptors in Alzheimer's disease

A Salasova, G Monti, OM Andersen… - Molecular …, 2022 - Springer
The family of VPS10p-Domain (D) receptors comprises five members named SorLA, Sortilin,
SorCS1, SorCS2 and SorCS3. While their physiological roles remain incompletely resolved …